Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India

International Journal of Preventive Medicine

Volumn 1, Issue 4, 2010, Pages 223-232

  Bagchi, Suparna ^a   Ambe, Guirish ^b   Sathiakumar, Nalini ^c  

^a Georgia Division of Public Health   (United States)

^b Mumbai Municipal Corporation   (India)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adherence; DOTS; Drug supply; Mumbai; Smoking; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; COST; FEMALE; HEALTH BELIEF; HEALTH CARE AVAILABILITY; HUMAN; INDIA; LIFESTYLE MODIFICATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT TRANSPORT; RISK FACTOR; SHORT COURSE THERAPY; SMOKING; TREATMENT REFUSAL;

EID: 79952053275     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282(7): 677-86.
2. Chakraborty AK. Prevalence and incidence of tuberculosis infection and disease in India: a comprehensive review. Geneva: WHO; 1997.
3. WHO. Joint tuberculosis control programme review India February 2000. In: Spiegelburg DD, Editor. New Topics in Tuberculosis Research. New York: Nova Publishers; 2006.
4. Morbidity and Mortality Weekly Report. Progress toward tuberculosis control in India. CDC 2002; 51(11): 229-32.
5. Khatri GR, Frieden TR. The status and prospects of tuberculosis control in India. Int J Tuberc Lung Dis 2000;4(3): 193-200.
6. Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med 2002; 347(18): 1420-5.
7. Naing NN, D'Este C, Isa AR, Salleh R, Bakar N, Mahmod MR. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients. Southeast Asian J Trop Med Public Health 2001; 32(2): 369-82.
8. O'Boyle SJ, Power JJ, Ibrahim MY, Watson JP. Factors affecting patient compliance with antituberculous chemotherapy using directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis 2002; 6(4): 307-12.
9. Comolet TM, Rakotomalala R, Rajaonarioa H. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis 1998; 2(11): 891-7.
10. Liam CK, Lim KH, Wong CM, Tang BG. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis 1999; 3(4): 300-9.
11. Tanguis HG, Cayla JA, Garcia de Olalla PG, Jansa JM, Brugal MT. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996). Int J Tuberc Lung Dis 2000; 4(1): 55-60.
12. Chuah SY. Factors associated with poor patient compliance with antituberculosis therapy in Northwest Perak, Malaysia. Tubercle 1991; 72(4): 261-4.
13. Cator M, Brassard P, Ducic S, Culman K. Factors related to non-compliance with active tuberculosis treatment in Montreal 1992-1995. Can J PublicHealth 2002; 93(2): 92-7.
14. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997; 111(5): 1168-73.
15. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144(4): 745-9.
16. Al-Hajjaj MS, Al-Khatim IM. High rate of noncompliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. Int J Tuberc Lung Dis 2000; 4(4): 345-9.
17. Singh V, Jaiswal A, Porter JD, Ogden JA, Sarin R, Sharma PP, et al. TB control, poverty, and vulnerability in Delhi, India. Trop Med Int Health 2002; 7(8): 693-700.
18. Manders AJ, Banerjee A, van den Borne HW, Harries AD, Kok GJ, Salaniponi FM. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase. Int J Tuberc Lung Dis 2001; 5(9): 838-42.
19. Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 2004; 4: 68.
20. Davidson H, Schluger NW, Feldman PH, Valentine DP, Telzak EE, Laufer FN. The effects of increasing incentives on adherence to tuberculosis directly observed therapy. Int J Tuberc Lung Dis 2000; 4(9): 860-5.
21. Sloan JP, Sloan MC. An assessment of default and non-compliance in tuberculosis control in Pakistan. Trans R Soc Trop Med Hyg 1981; 75(5): 717-8.